光正眼科医院集团股份有限公司 (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder: As of the date of this announcement, the total amount of external guarantees provided by the Company and its controlling subsidiaries exceeds 100% of the latest audited (attributable to the parent) net assets, all of which are mutual guarantees among the Company, its controlling subsidiaries, wholly-owned subsidiaries, and their subordinate companies. Investors are advised to pay attention to guarantee risks.
I. Overview
On April 22, 2026, the Company held the ninth meeting of the sixth Board of Directors, which reviewed and approved the proposal regarding the application for comprehensive credit limits and the provision of guarantees and counter-guarantees by the Company, subsidiaries, and their subordinate companies for the year 2026. To ensure the funding needs for the Company's normal operations based on the 2026 production and operation plan and development plan, the Company and its consolidated subsidiaries plan to apply for a total comprehensive credit limit not exceeding 620 million RMB (including but not limited to: credit loans, third-party guaranteed loans, asset mortgage loans, bank acceptance bills, bank guarantees, factoring, trade financing, acquisition loans, medical insurance loans, financial leasing, etc.) from banks and other relevant financial institutions. The Company will comprehensively consider the actual funding needs for production and operations, the credit situation with financial institutions, the credit scale of various banks and relevant financial institutions, financing terms, and financing costs to make optimal selections.